Lymphoma in common variable immunodeficiency: Interplay between immune dysregulation, infection and genetics

Current Opinion in Hematology

Volumn 15, Issue 4, 2008, Pages 368-374

  Chua, Ignatius ^a   Quinti, Isabella ^b   Grimbacher, Bodo ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Common variable immunodeficiency; Cytomegalovirus; Granulomatous variant; Helicobacter pylori; Human herpes virus type 8; Lymphoma; Radiosensitivity; Transmembrane activator and calcium modulating ligand interactor

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; IMMUNOGLOBULIN; LANSOPRAZOLE; METRONIDAZOLE; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR;

ANTIGEN SPECIFICITY; B LYMPHOCYTE; BACTERIAL INFECTION; CANCER RISK; COMMON VARIABLE IMMUNODEFICIENCY; CYTOLOGY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DISEASE COURSE; GENE IDENTIFICATION; GENE MUTATION; GENETIC DISORDER; GENETICS; HAEMOPHILUS INFECTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; IMMUNE DYSREGULATION; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; PERSISTENT INFECTION; PHENOTYPE; PRIORITY JOURNAL; PROPHYLAXIS; RADIOSENSITIVITY; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; T LYMPHOCYTE; VIRUS INFECTION; VIRUS TYPING; DISEASE PREDISPOSITION; IMMUNE DEFICIENCY; INFECTION; LYMPHOMA; RISK FACTOR;

COMMON VARIABLE IMMUNODEFICIENCY; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFECTION; LYMPHOMA; RISK FACTORS;

EID: 47149105458     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328302c7b6     Document Type: Review

References (55)

1. Schäffer A, Salzer U, Hammarström L, et al. Deconstructing common variable immunodeficiency by genetic analysis. Curr Opin Genet Dev 2007; 17: 201-212.
2. Ferry B, Jones J, Bateman E, et al. Measurements of peripheral B cell populations in common variable immunodeficiency using a whole blood method. Clin Exp Immunol 2005; 140:532-539.
3. Hermaszewski R, Webster A. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 1993; 86:31-42.
4. Cunningham-Rundles C, Cooper D, Duffy T, et al. Lymphomas of mucosal associated lymphoid tissues in common variable immunodeficiency. Am J Hematol 2002; 69:171-178.
5. Park J, Beal I, Dilworth J, et al. The HRCT appearances of granulomatous pulmonary disease in common variable immune deficiency. Eur J Radiol 2005; 54:359-364.
6. Christopher A, Bates M, Misoo E, et al. Granulocytic-lymphomatous lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol 2004; 114:415-421.
7. Warnatz K, Denz A, Drager R, et al. Severe deficiency of switched memory B cells (CD27+IgM-IgD-) in subgroups of patients with common variable immunodeficiency (CVID): a new approach to classify a heterogeneous disease. Blood 2002; 99:1544-1551.
8. Piqueras B, Lavenu-Bombled C, Galicier L, et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 2003; 5:385-400.
9. Rezaei N, Haji-Molla-Hoseini M, Aghamohammadi A, et al. Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical complications. J Clin Immunol 2008; 28:78-84.
10. Giovannetti A, Pierdominic M, MazzettaF, et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 2007; 178:3932-3943.
11. Fevang B, Yndestad A, Sandberg WJ, et al. Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo. Clin Exp Immunol 2007; 147:521-525.
12. Vorechovsky I, Zetterquist H, Paganelli R, et al. Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin Immunol Immunopathol 1995; 77:185-192.
13. Kralovicova J, Hammarstrom L, Plebani A, et al. Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency. J Immunol 2003; 170:2765-2775.
14. Vorechovsky I, Cullen M, Carrington M, et al. Fine mapping of IGAD1 in IgA deficiency and common variable immunodeficiency: identification and characterization of haplotypes shared by affected members of 101 multiple-case families. J Immunol 2000; 164:4408-4416.
15. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92:34-48.
16. Salzer U, Chapel H, Webster A, et al. Mutations in TNFRSF13B, which encodes TACI, are associated with common variable immunodeficiency in humans. Nat Genet 2005; 37:820-828.
17. Castigli E, Wilson S, Garibyan L, et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005; 37:829-834.
18. Warnatz K, Salzer U, Gutenberger S, et al. Finally found: human BAFF-R deficiency causes CVID [abstract #B. 72]. In: XIth Meeting of the European Society for Immunodeficiencies 21-24 October 2004; Versailles, France.
19. van Zelm M, Reisli I, van der Burg M, et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006; 354:1901-1912.
20. Grimbacher B, Hutloff A, Schlesier M, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003; 4:261-268.
21. Bacchelli C, Buckridge S, Thrasher A, et al. Molecular defects in common variable immunodeficiency. Clin Exp Immunol 2007; 149:401-409.
22. Shulga-Morskaya S, Dobles M, Walsh M, et al. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J Immunol 2004; 173:2331-2341.
23. Castigli E, Scott S, Dedeoglu F, et al. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci 2004; 101:3903-3908.
24. Yan M, Wang H, Chan B, et al. Activation and accumulation of B cells inTACI-deficient mice. Nat Immunol 2001; 2:638-643.
25. Salzer U, Birmelin J, Barchelli C, et al. Sequence analysis of TNFRSF13b, encoding TACI, in patients with systemic lupus erythematosus. J Clin Immunol 2007; 27:372-377.
26. Kinlen LJ, Webste AD, Bird AG, et al. Prospective study of cancer in patients with hypogammaglobulinacmia. Lancet 1985; 1:263-266.
27. Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, et al. Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol 1987; 7:294-299.
28. Mellemkjær L, Hammarstrom L, Andersen V, et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol 2002; 130:495-500.
29. Quinti I, Soresina A, Spadaro G, et al. Long term follow up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007; 27:308-316.
30. Grulich A, Leeuwen M, Falster M, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a metaanalysis. Lancet 2007; 370:59-67.
31. Gompels M, Hodges E, LockR, et al. Lymphoproliferative disease in antibody deficiency: a multicentre study. Clin Exp Immunol 2003; 134:314-320.
32. Filipovich A, Heinitz K, Robison L, et al. The Immunodeficiency Cancer Registry: a research resource. Am J Paediatr Hematol Oncol 1987; 9:183-184.
33. Cottier H, Kaft R, Meister F. Primary immunodeficiency syndromes and their manifestation in lymph nodes. Curr Top Pathol 1991; 84:81-155.
34. Harris N, Jaffe E, Stein H, et al.A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-1392.
35. Sander C, Medeiros L, Weiss L, et al. Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol 1992; 16:1170-1182.
36. Aghamohammadi A, Parvaneh N, Tigari F, et al. Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency. Leuk Lymphoma 2006; 47:343-346.
37. Desar I, Keuter M, Raemaekers J, et al. Extranodal marginal zone (malt) lymphoma in common variable immunodeficiency. Neth J Med 2006; 64:136-140.
38. Radaszkiewicz T, Dragosics B, Bauer P, et al. Gastrointestinal malignant lymphoma of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology 1992; 102:1628-1638.
39. Lecuit M, Abachin E, Martin A, et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004; 350:239-248.
40. Al-Saleem T, Al-Mondhiry H. Immunoproliferative small intestine disease (IPSID): a model for mature B cell neoplasms. Blood 2005; 105:2274-2280.
41. Fischbach W, Goebeler-Kolve M-E, Dragosics B, et al. Long term outcome with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 2004; 53:34-37.
42. Parsonnet J, Isaacson P. Bacteria infection and MALT lymphoma. N Engl J Med 2004; 350:213-215.
43. Lenze D, Berg E, Volkmer-Engert R, et al. Influence of antigen on the developement of MALT lymphoma. Blood 2006; 107:1141-1148.
44. Wheat W, Cool C, Yoshikazu M, et al. Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med 2005; 202:479-484.
45. Raeiszadeh M, Kopycinski J, Paston S, et al. The T cell response to persistent herpes virus infections in common variable immunodeficiency. Clin Exp Immunol 2006; 146:234-242.
46. Suarez F, Lortholary O, Hermine O, et al. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen driven lymphoprolifera-tion. Blood 2006; 107:3034-3044.
47. Hussell T, Isaacson P, Crabtree J, et al. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342:571-574.
48. He B, Raab-Traub N, Casali P, et al. EBV- encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to Induce T cell-independent Ig heavy chain class switching. J Immunol 2003; 171:521 5-5224.
49. Novak A, Grote D, Stenson M, et al. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood 2004; 104:2247-2253.
50. He B, ChadburnA, Jou E. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J Immunol 2004; 172:3268-3279.
51. Ng L, Mackay C, Mackay F. The BAFF/APRIL system: life beyond B lymphocytes. Mol Immunol 2005; 42:763-772.
52. Kern C, Cornuel J, Billard C, et al. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 2004; 103:679-688.
53. Thome M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat Rev Immunol 2004; 5:348-359.
54. Palanduz S, Palanduz A, Yalchin I, et al. In vitro chromosomal radiosensitivity in common variable immunodeficiency. Clin Immunol Immunopathol 1998; 86:180-182.
55. Vorechovsky I, Scott D, Haeney M, et al. Chromosomal sensitivity in common variable immunodeficiency. Mutat Res 1993; 290:255-264.